XXI century: changes in the Erice Declaration on drug safety
https://doi.org/10.14412/1995-4484-2019-244-245
Abstract
The article presents the provisions of the Erice Declaration on the safety of medicines and discusses the need for their transformation into the XXI century.
About the Authors
Yu. V. Muravyev
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
34A, Kashirskoe Shosse, Moscow, 115522
Russian Federation
34A, Kashirskoe Shosse, Moscow, 115522
L. A. Muravyeva
Central Polyclinic Department, Khimki Central Clinical Hospital
Russian Federation
2/21, Chkalov Str., Khimki, Moscow Region, 141400
Russian Federation
2/21, Chkalov Str., Khimki, Moscow Region, 141400
References
1. Muravyev YuV, Muravyevа LA. Debatable problems of pharmacovigilance. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2018;56(1):123-126 (In Russ.). doi: 10.14412/1995-4484-2018-123-126
2. Hugman B. The Erice declaration: the critical role of communication in drug safety. Drug Saf. 2006;29(1):91-3. doi: 10.2165/00002018-200629010-00007
3. Bowdler J. The Erice declaration: on communicating drug safety information. Prescrire Int. 1998;7(38):191.
4. Velo GP, Hugman B. The Erice Manifesto: for global reform of the safety of medicines in patient care. Drug Saf. 2007;30(3):187-90. doi: 10.2165/00002018-200730030-00001
5. Edwards IR. A New Erice Report Considering the Safety of Medicines in the 21st Century. Drug Saf. 2017;40(10):845-9. doi: 10.1007/s40264-017-0571-9
6. Aronson JK. Giampaolo Velo 1943-2017. Br J Clin Pharmacol. 2018;84(2):410-12. doi: 10.1111/bcp.13452
7. Institute of Medicine. Best care at lower cost: the path to continuously learning health care in America. Consensus Report. Washington, DC: NAS; 2012.
Review
For citations:
Muravyev Yu.V., Muravyeva L.A. XXI century: changes in the Erice Declaration on drug safety. Rheumatology Science and Practice. 2019;57(2):243-245. (In Russ.) https://doi.org/10.14412/1995-4484-2019-244-245
Views:
551
Email this article 